R & D to develop Execabase to combat S. aureus

SOL #: 21C00021Award Notice

Overview

Buyer

Health And Human Services
Office Of Assistant Secretary For Preparedness And Response
BARDA - ASPR / DAAPPO / BARDA DCMA
WASHINGTON, DC, 20515, United States

Place of Performance

Yonkers, NY

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

Medical And Surgical Instruments, Equipment, And Supplies (6515)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 11, 2021

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Not fixed price and not competetive.  Negotiated award based on Broad Agency Announcement

People

Points of Contact

No contacts available

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Award Notice
Posted: Mar 11, 2021
R & D to develop Execabase to combat S. aureus | GovScope